This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Stage IIIC Ovarian Cancer
and you are
between 18 and 75
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

Patients with advanced ovarian cancer (FIGO stage III C) and highly disseminated tumor will be randomized into two arms: primary debulking surgery followed by adjuvant chemotherapy vs. neoadjuvant chemotherapy followed by interval debulking surgery (IDS). The primary end point is the evaluation and comparison of the surgical complications of primary surgery and IDS and the evaluation of the progression free survival (PFS)

Provided treatments

  • Drug: Neoadjuvant chemotherapy + Interval Debulking Surgery
  • Procedure: Primary Debulking Surgery + Adjuvant Chemotherapy

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01461850. The sponsor of the trial is Catholic University of the Sacred Heart and it is looking for 171 volunteers for the current phase.
Official trial title:
Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm